Inhibikase Therapeutics, Inc. · NASDAQ:IKT

Nantahala Capital Management, LLC's stake in Inhibikase Therapeutics, Inc. fell to 4.30% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Nantahala Capital Management, LLC's stake in Inhibikase Therapeutics, Inc. fell to 4.30%, 5,810,487 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.30%
Shares
5,810,487
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC4.30%5,810,487
Wilmot B. Harkey4.30%5,810,487
Daniel Mack4.30%5,810,487

Source

View original at SEC

Related